<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>life-sciences</title>
    <link>https://pitchbook.com/tag/life-sciences</link>
    <description>life-sciences</description>
    <language>en-US</language>
    <lastBuildDate>Tue, 26 May 2026 20:35:33 GMT</lastBuildDate>
    <atom:link href="https://pitchbook.com/tag/life-sciences.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>PE's capital concentration phenomenon reaches new heights</title>
      <link>https://pitchbook.com/news/articles/pes-capital-concentration-phenomenon-reaches-new-heights</link>
      <description>The 10 largest funds accounted for more than half of all capital raised, with industrial-focused Triton and Greenbriar among the winners</description>
      <pubDate>Tue, 26 May 2026 20:35:33 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/pes-capital-concentration-phenomenon-reaches-new-heights</guid>
    </item>
    <item>
      <title>OpenAI’s life sciences push energizes VCs</title>
      <link>https://pitchbook.com/news/articles/openais-gpt-rosalind-heats-up-ai-competition-in-life-sciences</link>
      <description>OpenAI has jumped into a category startup investors assumed it'd avoid. But they're welcoming the move.</description>
      <pubDate>Fri, 17 Apr 2026 20:16:03 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/openais-gpt-rosalind-heats-up-ai-competition-in-life-sciences</guid>
    </item>
    <item>
      <title>Novo Nordisk Foundation commits $850M+ to European life sciences and deep tech</title>
      <link>https://pitchbook.com/news/articles/novo-nordisk-foundation-commits-850m-to-european-life-sciences-and-deep-tech</link>
      <description>The world's largest charitable organization looks to boost innovation through research body and startup builder BioInnovation Institute.</description>
      <pubDate>Thu, 15 Jan 2026 12:47:53 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/novo-nordisk-foundation-commits-850m-to-european-life-sciences-and-deep-tech</guid>
    </item>
    <item>
      <title>Tubulis lands European record $361M Series C for cancer drug</title>
      <link>https://pitchbook.com/news/articles/tubulis-lands-european-record-361m-series-c-for-cancer-drug</link>
      <description>Although Q1 recorded the continent's highest deal value to date, 2025 has since been a lackluster year for life sciences.</description>
      <pubDate>Wed, 15 Oct 2025 15:11:38 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/tubulis-lands-european-record-361m-series-c-for-cancer-drug</guid>
    </item>
    <item>
      <title>With lenders galore, life science companies find debt cheaper</title>
      <link>https://pitchbook.com/news/articles/with-lenders-galore-life-science-companies-find-debt-cheaper</link>
      <description>Lenders cut spreads and eased covenants for borrowers amid increased competition from other debt providers and pressure to deploy capital.</description>
      <pubDate>Wed, 02 Jul 2025 23:08:52 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/with-lenders-galore-life-science-companies-find-debt-cheaper</guid>
    </item>
    <item>
      <title>European life sciences kicks off year with deluge of VC capital</title>
      <link>https://pitchbook.com/news/articles/european-life-sciences-kicks-off-year-with-deluge-of-vc-capital</link>
      <description>Less than a month into Q1, the sector has already raised more than half of Q4's total deal value.</description>
      <pubDate>Wed, 15 Jan 2025 20:12:11 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/european-life-sciences-kicks-off-year-with-deluge-of-vc-capital</guid>
    </item>
    <item>
      <title>Blackstone targets $5 billion for latest life sciences fund</title>
      <link>https://pitchbook.com/news/articles/blackstone-targets-5-billion-for-latest-life-sciences-fund</link>
      <description>PE firms have increasingly been involved in funding drug development.</description>
      <pubDate>Mon, 09 Dec 2024 22:59:22 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/blackstone-targets-5-billion-for-latest-life-sciences-fund</guid>
    </item>
    <item>
      <title>Pharma services dealmaking nears quarterly record</title>
      <link>https://pitchbook.com/news/articles/pharma-services-dealmaking-nears-quarterly-record</link>
      <description>PE deal activity in the sector is riding tailwinds from M&amp;A-friendly interest rate policies and GPs' growing appetite for life sciences investments.</description>
      <pubDate>Tue, 19 Nov 2024 00:04:21 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/pharma-services-dealmaking-nears-quarterly-record</guid>
    </item>
    <item>
      <title>The 10 most active investors in European life sciences startups</title>
      <link>https://pitchbook.com/news/articles/top-investors-european-life-sciences-vc-deals</link>
      <description>Here are the 10 most active investors in European life sciences VC deals since 2017.</description>
      <pubDate>Wed, 26 Apr 2023 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/top-investors-european-life-sciences-vc-deals</guid>
    </item>
    <item>
      <title>New Mountain grows life science influence with $2.45B PerkinElmer deal</title>
      <link>https://pitchbook.com/news/articles/private-equity-life-sciences-deal-perkinelmer</link>
      <description>New Mountain Capital to acquire multiple business divisions of PerkinElmer, a life sciences and pharmaceutical company, for $2.45 billion—one of the largest recent private equity deals in the sector.</description>
      <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/private-equity-life-sciences-deal-perkinelmer</guid>
    </item>
    <item>
      <title>Apollo bets on life sciences with Sofinnova partnership</title>
      <link>https://pitchbook.com/news/articles/apollo-sofinnova-partnership-life-sciences</link>
      <description>Apollo Global Management has agreed to take a minority stake in life sciences venture capital firm Sofinnova Partners.</description>
      <pubDate>Mon, 16 May 2022 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/apollo-sofinnova-partnership-life-sciences</guid>
    </item>
    <item>
      <title>Moderna hits $7.6B in upsized debut [datagraphic]</title>
      <link>https://pitchbook.com/news/articles/moderna-hits-76b-in-upsized-debut</link>
      <description>The biotech has priced its IPO at $23 per share, raising roughly $604 million. We've put together a datagraphic of the company's financials, key shareholders, valuation history and more.</description>
      <pubDate>Thu, 06 Dec 2018 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/moderna-hits-76b-in-upsized-debut</guid>
    </item>
    <item>
      <title>Blackstone to try hand at life sciences with acquisition</title>
      <link>https://pitchbook.com/news/articles/blackstone-to-jump-into-life-sciences-with-acquisition</link>
      <description>Blackstone hasn't been shy about secondaries deals in 2018. The firm plans to go even further with a wholesale takeover of Clarus, a life sciences investment firm.</description>
      <pubDate>Thu, 04 Oct 2018 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/blackstone-to-jump-into-life-sciences-with-acquisition</guid>
    </item>
  </channel>
</rss>
